Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios
2015 · Genetics in Medicine · 337 citations
https://doi.org/10.1038/gim.2014.191
X
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
373
Papers
5.8K
Citations
38
h-index
107
i10-index
Xiaolin Zhu is an academic researcher from First Affiliated Hospital of Heilongjiang University of Chinese Medicine. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer, Lipids, and Metabolism & Cancer Immunotherapy and Biomarkers. The author has an h-index of 38, co-authored 318 publications.
ORCID: 0000-0002-3221-595XPapers by this author
worksMetformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
2016 · Journal of Hematology & Oncology · 74 citations
https://doi.org/10.1186/s13045-016-0253-6
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
2022 · Cell Death and Disease · 73 citations
https://doi.org/10.1038/s41419-022-05448-7
ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2
2018 · Cancer Letters · 57 citations
https://doi.org/10.1016/j.canlet.2018.04.013
Decreased expression of acetyl‐CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma
2017 · Cancer Science · 48 citations
https://doi.org/10.1111/cas.13252
A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression
2020 · Cancer Cell International · 43 citations
https://doi.org/10.1186/s12935-020-01471-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat